These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia. Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842 [TBL] [Abstract][Full Text] [Related]
3. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443 [TBL] [Abstract][Full Text] [Related]
4. A rapid and reversible change in dopamine transporters induced by methamphetamine. Fleckenstein AE; Metzger RR; Gibb JW; Hanson GR Eur J Pharmacol; 1997 Apr; 323(2-3):R9-10. PubMed ID: 9128855 [TBL] [Abstract][Full Text] [Related]
9. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine. Tsao LI; Cadet JL; Su TP Eur J Pharmacol; 1999 May; 372(3):R5-7. PubMed ID: 10395030 [TBL] [Abstract][Full Text] [Related]
10. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Frey K; Kilbourn M; Robinson T Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358 [TBL] [Abstract][Full Text] [Related]
11. An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Fricks-Gleason AN; German CL; Hoonakker AJ; Friend DM; Ganesh KK; Carver AS; Hanson GR; Fleckenstein AE; Keefe KA Synapse; 2016 Apr; 70(4):139-46. PubMed ID: 26799527 [TBL] [Abstract][Full Text] [Related]
12. Rapid and reversible effects of methamphetamine on dopamine transporters. Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348 [TBL] [Abstract][Full Text] [Related]
13. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Broening HW; Morford LL; Vorhees CV Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503 [TBL] [Abstract][Full Text] [Related]